Electrical Muscle Stimulator (AST-105DJ, AST-105EJ, AST- 105BJ, AST-105GJ, AST-303J, AST-309J, AST-310J;AST-300Q, AST-300Q-A, AST-500B; AST-500G, AST-500F; AST-500N; AST- 500C, AST- 500K, AST-500A; AST-300E, AST-500M, AST- 500U, AST- 500D; AST- 500E.)
Shenzhen Osto Medical Technology Co.,Ltd · Decision date Sep 6, 2026
What did the FDA decide?
K261131 records FDA's September 6, 2026 Substantially Equivalent (SESE) decision for an Electrical Muscle Stimulator submitted by Shenzhen Osto Medical Technology Co.,Ltd. The Traditional 510(k) was received April 6, 2026. FDA's database places the device under regulation 882.5890, classification product code NUH and subsequent product code NGX, with Neurology as both the specialty and review panel.
The device-name field enumerates AST-105, AST-300, AST-303, AST-309, AST-310 and AST-500 model variants. The classification name is an over-the-counter transcutaneous nerve stimulator. Those fields identify the reviewed product group, but do not describe which model was changed or added relative to a preceding submission. The available document excerpts do not establish the predicate or give complete model-by-model function specifications, so those relationships are left unspecified.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Neurology
- Decision date
- Sep 6, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261131
- Regulatory pathway
- 510(k) premarket notification
- Product code
- NUH
- Decision code
- SESE
- Decision date
- Sep 6, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, Nerve, Transcutaneous, Over-The-Counter.
- Product code
- NUH
- FDA device class
- 2
FDA decision timeline
K261131 received
Application receipt date recorded by FDA.
K261131 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code NUH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Hong Qiangxing (Shenzhen) Electronics Limited | 510(k) clearance | Oct 16, 2026 | FDA | |
| Shenzhen Dongdixin Technology Co., Ltd. | 510(k) clearance | Jun 26, 2026 | FDA | |
| Hivox Biotek, Inc. | 510(k) clearance | Jun 16, 2026 | FDA | |
TENS/EMS device (GUSE01)K253896 | Globalcare Medical Technology Co., Ltd. | 510(k) clearance | Mar 4, 2026 | FDA |
| Shenzhen Jiantuo Electronics Co., Ltd. | 510(k) clearance | Dec 31, 2025 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Shenzhen Osto Medical Technology Co.,Ltd
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Shenzhen
Sources and methodology
- Original FDA record: K261131
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


